Insider Trading History of Koestler Thomas P

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Koestler Thomas P since 2006. The trader's CIK number is 1373605. At the time of the last reporting, Koestler Thomas P was the Executive Vice Presi of Momenta Pharmaceuticals Inc. (stock ticker symbol MNTA). Also see all insider trading activities at Momenta Pharmaceuticals Inc.

Note that in the past Koestler Thomas P also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Momenta Pharmaceuticals Inc (MNTA) by Koestler Thomas P

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 MNTA 0 $0 0 $0 4,356 $0
2018 MNTA 0 $0 0 $0 5,734 $0

Yearly summary of insider trading at Merck & Co., Inc. (SGP) by Koestler Thomas P

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2009 SGP 0 $0 0 $0 14,000 $0
2008 SGP 0 $0 0 $0 15,000 $0
2007 SGP 0 $0 0 $0 30,000 $0
2006 SGP 0 $0 0 $0 12,000 $0


Insider trading activities at 2 companies by Koestler Thomas P:

1. Momenta Pharmaceuticals Inc (MNTA)

2. Merck & Co., Inc. (SGP)

Table 1. Insider trading of Momenta Pharmaceuticals Inc (MNTA) by Koestler Thomas P

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-06-20 MNTA Option Ex 4,356 .00 0
2018-06-20 MNTA Option Ex 5,734 .00 0

Table 2. Insider trading of Merck & Co., Inc. (SGP) by Koestler Thomas P

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2009-04-01 SGP Option Ex 14,000 .00 0
2008-04-25 SGP Option Ex 15,000 .00 0
2007-08-18 SGP Option Ex 30,000 .00 0
2006-12-01 SGP Option Ex 12,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Koestler Thomas P (Executive Vice Presi of Momenta Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.